DPP4 Antikörper (N-Term)
Kurzübersicht für DPP4 Antikörper (N-Term) (ABIN7865627)
Target
Alle DPP4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- anti-CD26 mouse monoclonal, EBS-CD-019, purified
-
Aufreinigung
- affinity chromatography
-
Immunogen
- synthetic peptide from the amino terminal region of CD26
-
Isotyp
- IgM kappa
-
-
-
-
Applikationshinweise
-
ICC/IF_dilution: 1:100-1:200 (0.5-1.0 μg/mL)
FACS_dilution: 0.5-1.0 μg/million cells in 0.1 ml
WB_dilution: 1:50-1:100 (1-2 μg/mL)
IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 100 μg/mL
-
Buffer
- PBS with 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- store at 2 - 8 °C
-
-
- DPP4 (Dipeptidyl-Peptidase 4 (DPP4))
-
Andere Bezeichnung
- CD26
-
Hintergrund
- EBS-CD-019 reacts with human CD26 (Dipeptidyl peptidase IV), a 110 kDa protein which occurs in the cell membrane of t-lymphocyte and is upregulated after activation. CD26 is also present on endothelial cells and also expressed on inactivated B-cells and natural killer cells and abundantly on epithelia. CD26 is implicated in a variety of biological functions including T-cell activation, cell adhesion with extracellular matrix such as fibronectin or collagens, and in HIV infection. Positive control: Human PBL or tonsil.
-
Pathways
- Peptide Hormone Metabolism, Regulation of Leukocyte Mediated Immunity
Target
-